Rizzuti, B.; Ceballos-Laita, L.; Ortega-Alarcon, D.; Jimenez-Alesanco, A.; Vega, S.; Grande, F.; Conforti, F.; Abian, O.; Velazquez-Campoy, A.
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds. Pharmaceuticals 2021, 14, 892.
https://doi.org/10.3390/ph14090892
AMA Style
Rizzuti B, Ceballos-Laita L, Ortega-Alarcon D, Jimenez-Alesanco A, Vega S, Grande F, Conforti F, Abian O, Velazquez-Campoy A.
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds. Pharmaceuticals. 2021; 14(9):892.
https://doi.org/10.3390/ph14090892
Chicago/Turabian Style
Rizzuti, Bruno, Laura Ceballos-Laita, David Ortega-Alarcon, Ana Jimenez-Alesanco, Sonia Vega, Fedora Grande, Filomena Conforti, Olga Abian, and Adrian Velazquez-Campoy.
2021. "Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds" Pharmaceuticals 14, no. 9: 892.
https://doi.org/10.3390/ph14090892
APA Style
Rizzuti, B., Ceballos-Laita, L., Ortega-Alarcon, D., Jimenez-Alesanco, A., Vega, S., Grande, F., Conforti, F., Abian, O., & Velazquez-Campoy, A.
(2021). Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds. Pharmaceuticals, 14(9), 892.
https://doi.org/10.3390/ph14090892
